Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Expert commentary discussing the complex interplay among NASH, obesity, and diabetes from Clinical Care Options (CCO)
Kenneth Cusi, MD, FACP, FACE, and Stephen A. Harrison, MD, COL (Ret.), FAASLD, explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments
Raymond E. Soccio, MD, PhD, summarizes the roles of weight loss and diabetes drugs in NASH
Philip N. Newsome, PhD, FRCPE, summarizes the roles of weight loss and diabetes drugs in NASH
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.